Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease
Trial ID or NCT#
NCT00398177,,,,,,,,
Status
RECRUITING
Purpose
The purpose of this study is to characterize the molecular and cell biology of the tumor cells in lymphoma.
Official Title
Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease
Eligibility Criteria
Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Inclusion Criteria:
- * Diagnosis of Hodgkin's disease or non-Hodgkin's lymphoma, any cellular classification, any stage, any grade.* Adult or pediatric patients receiving lymph node excision for purposes other than cancer therapy (i.e. tonsillectomy, sleep apnea).* A routine procedure for tissue collection is planned.* Ability to understand and the willingness to sign a written informed consent.
Exclusion Criteria:
- * Patients without NHL or Hodgkin's disease
Investigator(s)
Ronald Levy, MD
Medical oncologist,
Lymphoma specialist
Robert K. and Helen K. Summy Professor in the School of Medicine
Michael Khodadoust
Lymphoma specialist,
Cutaneous oncology specialist,
Hematologist,
Hematologist-Oncologist
Assistant Professor of Medicine (Oncology) and of Dermatology
Ash A. Alizadeh, MD/PhD
Medical oncologist,
Lymphoma specialist,
Cancer geneticist
Moghadam Family Professor
Contact us to find out if this trial is right for you.
Contact
Ami Okada
650-725-4968
View on ClinicalTrials.gov
